Latest Breaking News On - Vaccine business - Page 11 : comparemela.com

Flagship Pioneering Unveils Inzen Therapeutics Company developing new class of transformative medicines based on Thanokine Biology News provided by Share this article Share this article CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/  Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. Flagship created Inzen in 2017 to discover and develop a novel class of medicines based on a previously unrecognized area of biology that exerts broad and fundamental influence on cell state, discovered and named Thanokine ™ Biology by Flagship s scientists.  Flagship also announced the appointment of industry veteran Volker Herrmann, M.D., M.B.A. as the company s new Chief Executive Officer and Partner at Flagship Pioneering, succeeding founding CEO Douglas Cole. Dr. Cole is Chairman of Inzen and Managing Partner at Flagship.

United kingdomPete goughDouglas coleVolker herrmannNoubar afeyanInzen thanokineAxcella healthFlagship pioneeringChief executive officerManaging partnerFlagship labsThanokine biologyFlagship senior principalInzen chief operating officer jason parkChief operating officerGlobal lead pain